NAMPT and lung carcinoma: In lung cancer, Liu et al. have demonstrated that the level of the adipokine visfatin in the serum of BM patients increased significantly, but also that visfatin promotes cancer cell migration across BBB, in vitro, associated with the upregulation of the CC chemokine ligand 2 (CCL2) [25].